|
Major non-fatal adverse events (112 patients), univariate analysis
| | | | |
|
Age
|
1.02
|
1.00
|
1.03
|
0.001
|
|
Hypertension
|
1.46
|
1.06
|
2.03
|
0.02
|
|
History of cancer
|
1.56
|
1.11
|
2.20
|
0.009
|
|
Major non-fatal adverse events (112 patients), multivariate analysis
|
|
Age
|
1.49
|
1.06
|
2.118
|
0.022
|
|
Recurrent episodes of IE (19 patients), univariate analysis
|
|
Staphylococcus aureus infection
|
4.8
|
1.9
|
11.9
|
0.001
|
|
Right-sided endocarditis
|
7.4
|
2.9
|
18.9
|
0.001
|
|
Spondylodiscitis
|
6.8
|
2.6
|
17.8
|
0.004
|
|
Drug abuse
|
10.3
|
4.1
|
25.6
|
0.001
|
|
Recurrent episodes of IE (19 patients), multivariate analysis
|
|
Drug abuse
|
8.5
|
2.3
|
31
|
0.001
|
